Sleep Disorders Trial, Recruiting NCT05435794 Sponsor: ResMed Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05435794
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already taking part in the SunSAS study, or people who have had a sleep breathing test (polygraphy or polysomnography) that showed they are suitable for treatment with a CPAP machine or a mouth device (MAD) for obstructive sleep apnoea (OSA)
  • People who have had their sleep tested using a device called Sunrise
  • Men or women aged between 18 and 80 years old
  • People diagnosed with obstructive sleep apnoea who are considered suitable for either CPAP therapy or a mouth device (MAD)
  • People who are covered by a social security or health insurance scheme
  • People who have read and signed a consent form agreeing to take part

Who may not be able to join:

  • People who have already been treated for sleep apnoea using a CPAP machine or a mouth device (MAD) at any point in the last five years
  • People who have COPD (a chronic lung condition) or other respiratory (breathing) diseases
  • People for whom CPAP therapy or a mouth device (MAD) is medically unsuitable for any reason
  • People with unstable heart disease, or heart failure classified as severe (New York Heart Association class III or IV) (confirm with trial site)
  • People who would be unable to complete the full study for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33426100200

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ResMed
Registry
ClinicalTrials.gov
Start date
15 July 2022
Est. completion
15 October 2022

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To determine the evolution of deep slow-wave sleep at one year in OSA patients according to the treatment initiated by continuous positive pressure or mandibular advancement device (MAD).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov